Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xudong Haipu Pharmaceutical is a prominent Chinese pharmaceutical company established as a joint venture between Shanghai Pharmaceutical (Group) and Orient Overseas. The company specializes in the production of high-quality generic drugs, with a particular focus on injectable formulations for emergency and critical care. Its extensive product portfolio includes cardiovascular agents, anti-infectives, and clinical nutrition products. Xudong Haipu operates multiple state-of-the-art GMP-certified manufacturing facilities in Shanghai. As a key supplier to the Chinese healthcare system, the company provides essential medicines such as adrenaline and dopamine injections. The firm is dedicated to maintaining rigorous quality standards while expanding its reach in both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xudong Haipu.